EUVIMEDEUVIMED entdecken
Crossref

Anafilaxia fatal por ceftriaxona: Estudio inmunológico postmortem y revisión de la mortalidad por alergia a fármacos

Magdalena Caminoa Irisarri, Adela Pazmiño Oñate, Fernando Pineda de la Losa, Jesús Jurado Palomo, Mar Jiménez Lara, Álvaro Moreno Ancillo

Salux: revista de ciencias y humanidades · 02.11.2025 · 11 (20) · 22

DOI: 10.66423/dedh2208 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Salux: revista de ciencias y humanidades, online erschienen am 02.11.2025. Verfasst von Magdalena Caminoa Irisarri und 5 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Drug-induced allergic reactions may lead to fatal outcomes when not promptly recognized and treated. We report a fatal ceftriaxone-induced anaphylaxis with post‑mortem immunologic confirmation and provide an updated review on mortality from drug allergy. Case report: A 53‑year‑old woman with liver comorbidity and a history of β‑lactam reaction developed circulatory collapse after intravenous ceftriaxone, but who had tolerated cephalosporins in the last year. Serum tryptase peaked at 41.5 µg/L; total IgE was 2440 IU/mL; and in‑vitro ELISA‑BSA confirmed sensitization to ceftriaxone and cefuroxime.

Discussion

The post‑mortem analysis integrated clinical chronology, biomarkers, and immunologic assays, to establish a cephalosporin-mediated IgE reaction by recent sensitization. Recent evidence places mortality from drug‑induced anaphylaxis between 0.1 and 0.5 deaths per million person‑years, with antibiotics, contrast media, and anesthetic agents being the leading triggers.

Conclusions

Post‑mortem allergologic assessment is crucial to confirm the immunologic etiology and to guide preventive strategies. Proper documentation of allergy history and immediate access to epinephrine are essential to reduce preventable deaths. KEY WORDS Anaphylaxis; Drug Hypersensitivity; Cephalosporins; Ceftriaxone; Immunologic Tests; Postmortem; Mortality

Zitieren

APA

Irisarri, M. C., Oñate, A. P., Losa, F. P. D. L., Palomo, J. J., Lara, M. J., & Ancillo, Á. M. (2025). Anafilaxia fatal por ceftriaxona: Estudio inmunológico postmortem y revisión de la mortalidad por alergia a fármacos. Salux: revista de ciencias y humanidades, 11(20), 22. https://doi.org/10.66423/dedh2208

Vancouver

Irisarri MC, Oñate AP, Losa FPDL, Palomo JJ, Lara MJ, Ancillo ÁM. Anafilaxia fatal por ceftriaxona: Estudio inmunológico postmortem y revisión de la mortalidad por alergia a fármacos. Salux: revista de ciencias y humanidades. 2025;11(20):22. doi:10.66423/dedh2208

BibTeX
@article{Irisarri2025,
  author = {Irisarri, Magdalena Caminoa and Oñate, Adela Pazmiño and Losa, Fernando Pineda de la and Palomo, Jesús Jurado and Lara, Mar Jiménez and Ancillo, Álvaro Moreno},
  title = {Anafilaxia fatal por ceftriaxona: Estudio inmunológico postmortem y revisión de la mortalidad por alergia a fármacos},
  journal = {Salux: revista de ciencias y humanidades},
  year = {2025},
  volume = {11},
  number = {20},
  pages = {22},
  doi = {10.66423/dedh2208}
}
Kostenlos starten →